Nail Your Sales Interview with the 30/60/90 Day Sales Plan
If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.

Now you can nail your interview with the 30 60 90 Day Sales Plan template with Audio Coaching. This simple tool will help you knock the socks off your interviewer and bury your competition.

To get the details: Click Here

[Close Window]
Medical Sales Jobs Websites - the best Medical Sales Jobs | Laboratory Sales Jobs | Medical Device Sales Jobs

FDA Grants Full Approval for SPRYCEL (dasatinib) for the Treatment of Adults with Chronic Myeloid Leukemia Who Are Resistant or Intolerant to Prior Therapies Including Gleevec*

May 26th, 2009
by admin.

Two-Year Follow-Up Data Includes Eighty PERCENT Progression-Free Survival Rate in Gleevec-Resistant or Intolerant Patients with Chronic Phase CML NEW YORK–(HSMN NewsFeed)–Bristol-Myers Squibb Company (NYSE: BMY ) today announced that the U.S. Food and Dru…
Biopharmaceuticals, Oncology
Bristol-Myers Squibb, SPRYCEL, dasatinib, chronic myeloid leukemia

FDA Grants Full Approval for SPRYCEL (dasatinib) for the Treatment of Adults with Chronic Myeloid Leukemia Who Are Resistant or Intolerant to Prior Therapies Including Gleevec*

Posted in: Medical Sales Jobs.

← FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
Boston Scientific Welcomes Results of Brain Aneurysm Medical Trial →

0 Comments on “FDA Grants Full Approval for SPRYCEL (dasatinib) for the Treatment of Adults with Chronic Myeloid Leukemia Who Are Resistant or Intolerant to Prior Therapies Including Gleevec*”

Leave a Comment